Back to results

CompletedPhase 2

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

NCT01603069

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Birmingham, Alabama, United States

+12 additional locations

View on ClinicalTrials.gov

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease — TrialFind